DNMT1 and Parkinson disease: Further evidence indicates that DNMT1 expression is reduced in PD patient brains and in α-synuclein transgenic mice, with DNMT1 thought to be sequestered in the cytoplasm by α-synuclein, leading to hypo-methylated CpGs (Desplats et al. 2011).